Tan, M.H., Mcallister, I.L., Gillies, M.E., Verma, N., Banerjee, G., Smithies, L.A., Wong, W.-L. and Wong, T.Y. (2014) Randomized Controlled Trial of Intravitreal Ranibizumab versus Standard Grid Laser for Macular Edema Following Branch Retinal Vein Occlusion. American Journal of Ophthalmology, 157, 237-247.
http://dx.doi.org/10.1016/j.ajo.2013.08.013

has been cited by the following article:

• TITLE: A Long-Term Study of Efficacy of Patients with Macular Edema Secondary to BRVO Treated with Ranibizumab Combined with Compound Salvia

  AUTHORS: Yalan Feng, Xingwei Wu

  KEYWORDS: Branch Retinal Vein Occlusion, Macular Edema, Long-Term Follow-Up, Ranibizumab, Compound Salvia

  JOURNAL NAME: Chinese Medicine, Vol.6 No.3, September 11, 2015

  ABSTRACT: Purpose: To study the long-term efficacy of intravitreal ranibizumab injection combined with in-travenous compound salvia injection drip in the treatment of patients with macular edema sec-ondary to branch retinal vein occlusion(BRVO). Methods: Sixty-five patients of branch retinal vein occlusion with macular edema were analyzed retrospectively. Thirty-seven patients in the treat-ment group were treated with ranibizumab injection combined with intravenous compound salvia injection drip, twenty-eight patients in the control group were treated with ranibizumab injection only. All patients were recorded and analyzed changes of clinical efficacy after 3 months, 6 months after a course of treatment of 6 months. Results: During 3 months after 6 months’ treatment, there were 5 patients having recurrence in the treatment group, while there were 9 in control group, the rate of recurrence between the two groups had significant difference (P